Stocks · US
DXCM
XNAS
DexCom, Inc.
An overview for this page is not available in English yet. The figures below are updated daily.
Key figures 2026-10-06 basis
P/E32.80x
P/B12.51x
P/S6.60x
EPS$2.65
ROE38.14%
ROA15.49%
Dividend yield0.00%
EV/EBITDA23.47x
Debt/Equity0.47
Free cash flow$1.4B
Returns and 52-week range
1W-3.75%
1M-5.13%
3M+12.60%
6M+32.13%
1Y+24.37%
YTD+25.32%
52W high$92.59
52W low$54.11
From 52W high-9.94%
Company
Peers in the same sector
| Company | Market cap | P/E | P/B | 1M |
|---|---|---|---|---|
| Biogen Inc. Common Stock | $33.0B | 39.58 | 1.75 | +0.93% |
| 센틴 | $31.8B | — | 1.41 | -3.62% |
| BeOne Medicines Ltd. American Depositary Shares | $40.9B | 62.39 | 7.91 | +1.26% |
| 레즈메드 | $31.3B | 20.58 | 4.76 | -3.35% |
| Idexx Laboratories Inc | $41.5B | 36.43 | 25.75 | -3.73% |
| Alcon Inc. Ordinary Shares | $31.1B | 70.68 | 1.59 | -10.37% |
Sources and notes
This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.